Monash researchers have developed a drug that can be potentially given as a preventative against heart attack. The drug—which has been studied in human cells and animal models—literally blocks the minute changes in blood ...
Jul 22, 2020
1
849
A new Northwestern Medicine study in mice found a widely used class of drugs to treat patients with hypertension, cardiovascular disease and diabetic kidney disease—many of whom are elderly—does not increase the risk ...
Jul 22, 2020
0
0
Hydroxychloroquine and azithromycin may have a serious impact on the cardiovascular system and are a potentially lethal combination, according to a large analysis of a World Health Organization (WHO) database on adverse drug ...
May 25, 2020
0
163
The U.S. Food and Drug Administration has granted approval for Farxiga (dapagliflozin) oral tablets to treat adults with heart failure with reduced ejection fraction, the agency announced Tuesday.
May 7, 2020
0
1
Two newer types of medications commonly used to treat type 2 diabetes are similar in their ability to reduce major heart complications, including heart attack, stroke and death from cardiovascular disease, according to research ...
Mar 31, 2020
0
0
Higher levels of the omega-3 fatty acid eicosapentaenoic acid (EPA) found in the blood—and not a decrease in triglyceride levels as originally thought—appear to explain the striking reductions in cardiovascular events ...
Mar 30, 2020
0
1
A University of Otago researcher has made an innovative discovery which paves the way for advances in treating cardiovascular disease including high blood pressure.
Jan 14, 2020
0
76
Researchers at Karolinska Institutet in Sweden and their colleagues in Germany, the U.S. and Finland have studied the safety of very long-term antipsychotic therapy for schizophrenia. According to the study, which is published ...
Jan 10, 2020
7
171
New research has shown the potential for clinically available cancer treatments to treat chronic obstructive pulmonary disease (COPD).
Jan 6, 2020
0
298
Findings from a new study led by researchers at Dartmouth's Geisel School of Medicine and Harvard Medical School and published in the journal Circulation: Cardiovascular Quality and Outcomes, show that the way in which pharmaceutical ...
Nov 15, 2019
0
1
